Compare NOV Inc. Common Stock (NOV) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NOV Inc. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? NOV Inc. Common Stock trades at $18.97 (market cap $6.77B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.73 (market cap $2.27B). The key difference: NOV Inc. Common Stock is far larger — about 3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and NOV Inc. Common Stock pays a 1.9% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| NOV | SLS | |
|---|---|---|
Market Cap | $6.77B | $2.27B |
Volume | 3,592,724 | 4,179,659 |
Sector | Energy | Health |
52-Week High | $21.71 | $15.46 |
52-Week Low | $12.31 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $7.93B | $2.14B |
Dividend Yield | 1.9% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
